KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardelyx (ARDX) EBT (2016 - 2025)

Ardelyx's EBT history spans 13 years, with the latest figure at -$400000.0 for Q4 2025.

  • For Q4 2025, EBT fell 108.55% year-over-year to -$400000.0; the TTM value through Dec 2025 reached -$60.6 million, down 55.98%, while the annual FY2025 figure was -$60.6 million, 55.98% down from the prior year.
  • EBT reached -$400000.0 in Q4 2025 per ARDX's latest filing, up from -$867000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $10.7 million in Q4 2022 to a low of -$45.2 million in Q2 2021.
  • Average EBT over 5 years is -$19.5 million, with a median of -$24.6 million recorded in 2022.
  • The largest YoY upside for EBT was 129.83% in 2023 against a maximum downside of 366.19% in 2023.
  • A 5-year view of EBT shows it stood at -$36.2 million in 2021, then soared by 129.52% to $10.7 million in 2022, then tumbled by 366.19% to -$28.5 million in 2023, then soared by 116.44% to $4.7 million in 2024, then crashed by 108.55% to -$400000.0 in 2025.
  • Per Business Quant, the three most recent readings for ARDX's EBT are -$400000.0 (Q4 2025), -$867000.0 (Q3 2025), and -$19.1 million (Q2 2025).